Do You Need a License to Sell Peptides in California?

There is no standalone peptide license in California. What actually determines your obligations is which lane your business sits in: ordinary commercial registration — entity filing, a seller's permit, local business licensing — versus the separate frameworks that govern drug distribution and licensed clinical practice, versus the supply of research-use-only materials to qualified business and research buyers. Those are three different questions with three different answers, and only your attorney and the relevant state agencies can resolve them against the model you are actually running. Everything below is informational and is not legal advice.

Which lane your business is actually operating in

Operators get stuck because they search for a permit by product name. Regulators do not organize licensing that way. They organize it by activity — what you do to the material, who you sell it to, and what you claim about it. Two businesses can hold the same vial and sit in entirely different regulatory positions because one relabels and markets it and the other resells it sealed, labeled, and documented to a business buyer.

Before you spend money on counsel, map your own activity honestly. The table below is not a determination of what any framework requires — it is a way to arrive at your first meeting with the right question already framed.

The pattern worth noticing: the further right you move down that table, the more the answer depends on facts about your business rather than facts about the compound. A supplier cannot license you into a lane, and no supplier should tell you which lane you are in.

Research use only is a designation, not a disclaimer

The phrase carries weight because it describes what the material is and how it may move, not because it appears in small print. Research-use-only peptides are not FDA-approved drugs, are not manufactured or supplied for human consumption, and are intended for laboratory research by qualified buyers. That designation travels with the material through every hand it passes through, including yours.

What that means practically for a reseller is narrower than most people assume. You can build a catalog, hold inventory, publish specifications, and serve business customers who buy for research purposes. What you cannot do — without changing your regulatory position entirely — is market the material for human use, make therapeutic claims about it, describe administration, or repackage it into anything that looks like a consumer or patient-facing product. The moment your copy or packaging implies human use, the RUO designation stops protecting the transaction and starts documenting the problem.

This is also where honest evidence framing matters commercially. Where published research exists on a given compound, it is frequently preclinical or early-stage. Research suggests areas of interest; it rarely settles anything. Marketing copy that outruns that distinction becomes a liability for the reseller who published it, not for the manufacturer upstream. Conservative, accurate product descriptions are the cheapest compliance control you will ever implement.

The questions to put in front of counsel and the state agencies

Bring a list. Attorneys bill for the time it takes you to figure out what you are asking, and state agencies answer narrow questions far better than broad ones. A workable starting list:

• Entity and tax registration. Is the business properly formed and registered, and does the way you sell — wholesale, retail, or both — change what you need to hold for sales and use tax purposes?
• Resale documentation. If you buy for resale, what does the supplier need from you, and what do you need to keep on file to support the treatment of those purchases?
• Local licensing. City and county requirements are separate from state ones and are easy to miss when a business operates online or from a small facility.
• Whether your activity falls under any distribution licensing framework. Do not assume the answer in either direction. Ask it plainly, describe your actual workflow, and get the response in writing.
• Scope of practice, if licensed professionals are involved. This is a question for the relevant professional board, and it belongs to the practice, not to a supplier.
• Labeling and advertising. What may appear on your site, your invoices, your packaging, and your sales scripts — and what may not.
• Recordkeeping. How long you retain purchase records, batch documentation, customer qualification records, and shipping records, and in what form.

Notice that none of these questions are about peptides specifically. They are about how a business acquires, holds, describes, and transfers regulated or semi-regulated goods. That is the frame a regulator will use if they ever look at you, so it is the frame worth adopting first.

The paperwork that protects you downstream

A reseller's real exposure usually is not the license they failed to obtain. It is the file they cannot produce eighteen months later when a customer, an insurer, a payment processor, or an agency asks a routine question.

The file that answers those questions is boring and specific: a certificate of analysis for every batch you have sold, tied to a lot number that appears on the physical unit; the supplier agreement or terms under which you purchased; your own purchase records and inbound receipts; records showing how you qualified the buyer as a business or research purchaser; and copies of the product descriptions and claims that were live on your site at the time of sale. Archive the last one. Website copy changes, and the version that mattered is the version that was published.

Build the file from day one, because reconstructing it is close to impossible. If a supplier cannot give you batch-level documentation on request, you are not building that file — you are hoping you never need it. Payment processors in this category are unusually sensitive, and the operators who lose accounts are almost always the ones who cannot produce documentation quickly when it is requested.

How to vet a wholesale supplier before you commit

The supplier you choose determines whether your compliance file is possible to maintain. A handful of checks separate a workable partner from an expensive mistake.

Ask for a COA before you place an order, and check whether you can verify it independently. Some suppliers publish lab results openly. Others send a PDF on request. A few charge for documentation or produce it only for large accounts — treat that as disqualifying. Documentation you paid extra for is documentation the supplier did not consider standard.

Read the COA rather than filing it. It should name the compound, carry a lot number that matches the physical unit, state the analytical method used, and be recent enough to correspond to the batch you are buying. A certificate with no lot number is a marketing asset, not a record.

Test pricing transparency early. Suppliers who will not discuss tier structure or order minimums until you have submitted contact details and sat through a call are telling you something about how they will behave when you need a straight answer later. Margins vary widely with volume, category, and how you position your catalog; what you need is a structure you can plan against, not a number pulled from someone else's business.

Confirm where fulfillment originates and what happens when something goes wrong. Domestic fulfillment shortens lead times and simplifies the customs and documentation questions that international sourcing raises. Ask what the replacement process looks like for a damaged or short shipment before you need it.

Check catalog depth against your plan. Stocking a narrow line is fine until customers ask for adjacent categories and you have to open a second supplier relationship with a second set of documentation standards. Looking at how a supplier organizes its popular research compounds alongside more specialized categories tells you whether one account can carry your catalog.

What Real Peptides does differently

Real Peptides supplies research-use-only peptides to business buyers through its Wholesale Partner Program, and the program is built around the documentation problem described above.

Every compound is produced to 99%+ HPLC purity and moves through batch-level panel testing — identity, purity, and contamination screening — before it is released. Certificates of analysis are published and verifiable rather than sold, sent selectively, or summarized. A buyer can check the lab results independently, which is the entire point: documentation only functions as protection if the person relying on it can confirm it without asking permission.

Fulfillment runs from within the United States, with orders shipping in five to seven days, so lead times stay predictable enough to plan inventory around. Wholesale pricing is tiered by volume and disclosed to approved accounts rather than concealed behind a discovery call.

Account qualification runs through a three-step application: submit business details, complete verification, and receive tier pricing and ordering access. It is a business-verification process, not a licensing determination — Real Peptides does not and cannot assess whether your model satisfies obligations in your state, and no supplier that tells you otherwise is worth trusting on anything else either.

Where a qualified buyer goes from here

If you have mapped your activity, put the licensing questions in front of your attorney and the relevant state agencies, and decided that stocking research-use-only compounds fits your business, the remaining work is choosing a supplier whose documentation you can stand behind. The Wholesale Partner Program application takes a few minutes and produces tier pricing you can actually model against before you commit to inventory.

Related reading: the wholesale peptides program page covers tier structure and account terms in detail, the broader question of do you need a license to sell peptides is addressed across jurisdictions, and qualified businesses can apply for a wholesale account directly.